Jump to content

Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Isopropamide: Difference between pages

(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 456925987 of page Isopropamide for the Chem/Drugbox validation project (updated: 'ChEMBL', 'CAS_number').
 
Citation bot (talk | contribs)
Add: doi. | Use this bot. Report bugs. | Suggested by Whoop whoop pull up | #UCB_webform 1580/2023
 
Line 1: Line 1:
{{Short description|Chemical compound}}
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Isopropamide|oldid=456925987}} 456925987] of page [[Isopropamide]] with values updated to verified values.}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 400122296
| verifiedrevid =
| IUPAC_name = 4-amino-''N,N''-diisopropyl-''N''-methyl-4-oxo-3,3-diphenylbutan-1-aminium
| IUPAC_name = 4-amino-''N,N''-diisopropyl-''N''-methyl-4-oxo-3,3-diphenylbutan-1-aminium
| image = Isopropamide.png
| image = Isopropamide.png
Line 14: Line 15:
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S8 -->
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = Rx-only, Unscheduled
| legal_US = Rx-only
| legal_US_comment = and Unscheduled
| legal_status = Unscheduled
| legal_status = Unscheduled
| routes_of_administration = Oral
| routes_of_administration = Oral
Line 23: Line 25:
| metabolism =
| metabolism =
| elimination_half-life =
| elimination_half-life =
| excretion =
| excretion =


<!--Identifiers-->
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number_Ref = {{cascite||??}}
| CAS_number = <!-- blanked - oldvalue: 71-81-8 -->
| CAS_number = --
| ATC_prefix = A03
| ATC_prefix = A03
| ATC_suffix = AB09
| ATC_suffix = AB09
| PubChem = 3775
| PubChem = 3775
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank_Ref = {{drugbankcite||drugbank}}
| DrugBank = DB01625
| DrugBank = DB01625
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3643
| ChemSpiderID = 3643
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII_Ref = {{fdacite||FDA}}
| UNII = 8B9I31H724
| UNII = 8B9I31H724
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = <!-- blanked - oldvalue: 1201232 -->
| ChEMBL = 1201232

| C=23 | H=33 | N=2 | O=1 <sup>+</sup>
<!--Chemical data-->
| molecular_weight = 353.52092 g/mol
| C=23 | H=33 | N=2 | O=1 +
| smiles = O=C(N)C(c1ccccc1)(c2ccccc2)CC[N+](C(C)C)(C(C)C)C
| smiles = O=C(N)C(c1ccccc1)(c2ccccc2)CC[N+](C(C)C)(C(C)C)C
| InChI = 1/C23H32N2O/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26)/p+1
| InChIKey = JTPUMZTWMWIVPA-IKLDFBCSAQ
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C23H32N2O/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26)/p+1
| StdInChI = 1S/C23H32N2O/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26)/p+1
Line 49: Line 50:
| StdInChIKey = JTPUMZTWMWIVPA-UHFFFAOYSA-O
| StdInChIKey = JTPUMZTWMWIVPA-UHFFFAOYSA-O
}}
}}

'''Isopropamide''' ('''R79''') is a long-acting [[anticholinergic]] [[drug]]. It is used in the treatment of [[peptic ulcer]]s and other [[gastrointestinal disorder]]s involving hyperacidity (gastrointestinal [[acidosis]]) and hypermotility. Chemically, it contains a [[quaternary ammonium]] group. It is most often provided as an [[iodide]] salt, but is also available as a bromide or chloride salt. It was discovered at [[Janssen Pharmaceutica]] in 1954.

==References==
{{Reflist}}

== Further reading ==
{{refbegin}}
* {{cite journal | vauthors = Seeherman R | title = Isopropamide iodide: a long-acting anticholinergic | journal = Delaware Medical Journal | volume = 29 | issue = 10 | pages = 265–9 | date = October 1957 | pmid = 13473394 }}
* {{cite journal | vauthors = Boss Jr EG, Buchanan GC | title = Effect of isopropamide iodide on basal gastric secretion in the human | journal = Gastroenterology | volume = 33 | issue = 5 | pages = 730–6 | date = November 1957 | doi = 10.1016/S0016-5085(19)35625-2 | pmid = 13480414 }}
{{refend}}

{{Drugs for functional gastrointestinal disorders}}
{{Muscarinic acetylcholine receptor modulators}}

[[Category:Muscarinic antagonists]]
[[Category:Quaternary ammonium compounds]]
[[Category:Carboxamides]]
[[Category:Janssen Pharmaceutica]]
[[Category:Belgian inventions]]
[[Category:Diisopropylamino compounds]]

{{gastrointestinal-drug-stub}}